AIkido Pharma (AIKI)

AIkido Pharma (AIKI) Stock Price & Analysis


AIKI Stock Chart & Stats

Day’s Range$3.5 - $3.67
52-Week Range― - ―
Previous Close$3.55
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$42.56M
Total Debt (Recent Filing)$743.00K
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares Outstanding5,252,555
Standard Deviation0.23
10 Day Avg. Volume35,094
30 Day Avg. Volume34,277
Price to Book (P/B)0.26
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside349.44% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was AIkido Pharma’s price range in the past 12 months?
Currently, no data Available
What is AIkido Pharma’s market cap?
Currently, no data Available
When is AIkido Pharma’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AIkido Pharma’s earnings last quarter?
Currently, no data Available
Is AIkido Pharma overvalued?
According to Wall Street analysts AIkido Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
    Does AIkido Pharma pay dividends?
    AIkido Pharma does not currently pay dividends.
    What is AIkido Pharma’s EPS estimate?
    AIkido Pharma’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does AIkido Pharma have?
    Currently, no data Available
    What happened to AIkido Pharma’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of AIkido Pharma?
    Currently, no hedge funds are holding shares in AIKI


    AIkido Pharma Stock Smart Score

    This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
    Learn more about TipRanks Smart Score

    Company Description

    AIkido Pharma

    Spherix, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.


    Forecast EPS vs Actual EPS

    Currently, no data available
    Please return soon. This page is being updated.

    Similar Stocks
    Price & Change
    Forte Biosciences
    GeoVax Labs
    Aprea Therapeutics
    Enzon Pharmaceuticals

    Popular Stocks

    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis